Delivery Order SPE2DB22D1106-SPE2DB25FFFB4
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,061.52 to AmerisourceBergen Drug Corp for BELBUCA 300 MCG Film (60 count) on July 25, 2025, with completion expected by July 28, 2025. This is a firm fixed price, non-set-aside contract executed as a child order under AmerisourceBergen's broader pharmaceutical supply agreements with DLA. The product is a buccal film formulation used for pain management, reflecting the company's role as a critical pharmaceutical distributor for...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on August 18, 2025, for the supply of Belbuca 600 MCG Film in quantities of 60 units. This competitively awarded, firm fixed-price delivery order has a ceiling value of $1,121.71 and an ultimate completion date of August 19, 2025. The award was made by the Defense Logistics Agency (DLA), the Department of Defense's logistics organization responsible for...
- The Defense Logistics Agency awarded a delivery order valued at $4,370.61 to AmerisourceBergen Drug Corp for the supply of Belbuca 600 MCG film (60 count), a pharmaceutical product used in pain management. This contract is a firm fixed price delivery order with an ultimate completion date of August 12, 2025, and represents a non-set-aside competitive award. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency issued a delivery order valued at $2,180.68 to AmerisourceBergen Drug Corp for the supply of Belbuca 900 mcg film (60-count package), a buprenorphine transdermal product used for pain management. This competitively awarded, firm fixed price delivery order was placed on August 1, 2025, with an ultimate completion date of August 4, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a...
- The Defense Logistics Agency awarded a delivery order valued at $1,078.44 to AmerisourceBergen Drug Corp for Belbuca 150 mcg film (60 units) on August 15, 2025, with an ultimate completion date of August 18, 2025. This firm fixed price, competitively awarded contract (no set-aside designation) represents a routine pharmaceutical supply delivery to support federal medical procurement needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,644.43 to AmerisourceBergen Drug Corp for Belbuca 300 mcg film (60 count) on August 14, 2025, with an ultimate completion date of August 15, 2025. This firm fixed-price delivery order, which is not set aside, represents a pharmaceutical supply delivery under the company's larger indefinite delivery contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a...
- This is a $1,808.38 delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BELBUCA 300 MCG FILM 60S, a pain management pharmaceutical product. The contract is a firm fixed-price delivery order with a completion date of July 8, 2025. It is not a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
- This is a $1,000.47 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of BELBUCA 900 MCG FILM 60S, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of April 14, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for BELBUCA 450 MCG Film in a quantity of 60 units, with a ceiling value of $1,053.12. This firm fixed price contract, awarded on July 23, 2025, represents a delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award carries no set-aside designation, indicating it was...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract, valued at $1,133.26, is for the delivery of the pharmaceutical product "BELBUCA 900 MCG FILM 60S" with a completion date of May 15, 2024. Amerisourcebergen, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFFB4Delivery Order
The Defense Logistics Agency awarded a $2,320.49 delivery order to AmerisourceBergen Drug Corp for BELBUCA 750 MCG Film 60s, a pharmaceutical product used for pain management. This competitively awarded contract, issued on August 25, 2025, carries a firm fixed price and is scheduled for ultimate completion on August 26, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement through its comprehensive IDC vehicle that supplies pharmaceuticals, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs globally. The company's portfolio demonstrates extensive experience fulfilling varied federal medical supply requirements through competitively awarded contracts with the Defense Logistics Agency, serving customers including the Defense Health Agency and the U.S. Coast Guard. This delivery order for BELBUCA reflects the company's ongoing role in supplying specialty medications and pain management pharmaceuticals to support defense and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 8/25/25 |